The CD4+ T cell-mediated IFN-γ response to Helicobacter infection is essential for clearance and determines gastric cancer risk

Journal of Immunology

Volumn 182, Issue 11, 2009, Pages 7085-7101

  Sayi, Ayca ^a   Kohler, Esther ^a   Hitzler, Iris ^a   Arnold, Isabelle ^a   Schwendener, Reto ^a   Rehrauer, Hubert ^a   Müller, Anne ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATROPHY; CANCER RISK; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; EFFECTOR CELL; EPITHELIUM HYPERPLASIA; HELICOBACTER FELIS; HELICOBACTER INFECTION; HISTOPATHOLOGY; HOST SUSCEPTIBILITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTESTINE METAPLASIA; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRECANCER; PRIMARY INFECTION; PRIORITY JOURNAL; STOMACH CANCER; STOMACH EPITHELIUM; STOMACH LESION; STOMACH PROTECTION; ADOPTIVE TRANSFER; ANIMAL; DISEASE MODEL; EPITHELIUM CELL; GENETIC TRANSCRIPTION; IMMUNOLOGY; MICROBIOLOGY; RISK; SECRETION; STOMACH TUMOR; VACCINATION;

ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; HELICOBACTER INFECTIONS; INTERFERON-GAMMA; MICE; RISK; STOMACH NEOPLASMS; TRANSCRIPTION, GENETIC; VACCINATION;

EID: 67449126811     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803293     Document Type: Article

References (50)

1. Parsonnet, J., G. D. Friedman, D. P. Vandersteen, Y. Chang, J. H. Vogelman, N. Orentreich, and R. K. Sibley. 1991. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 325: 1127-1131.
2. Parsonnet, J., S. Hansen, L. Rodriguez, A. B. Gelb, R. A. Warnke, E. Jellum, N. Orentreich, J. H. Vogelman, and G. D. Friedman. 1994. Helicobacter pylori infection and gastric lymphoma. N. Engl. J. Med. 330: 1267-1271. (Pubitemid 24129959)
3. Parsonnet, J., and P. G. Isaacson. 2004. Bacterial infection and MALT lymphoma. N. Engl. J. Med. 350: 213-215.
4. Danesh, J. 1999. Helicobacter pylori infection and gastric cancer: systematic review of the epidemiological studies. Aliment Pharmacol. Ther. 13: 851-856.
5. Marshall, B. J., and J. R. Warren. 1984. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1: 1311-1315.
6. Pritchard, D. M., and J. E. Crabtree. 2006. Helicobacter pylori and gastric cancer. Curr. Opin. Gastroenterol. 22: 620-625.
7. Parkin, D. M., P. Pisani, and J. Ferlay. 1999. Estimates of the worldwide incidence of 25 major cancers in 1990. Int. J. Cancer 80: 827-841.
8. Murray, C. J., and A. D. Lopez. 1997. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 349: 1498-1504.
9. Lauren, P. 1965. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma: an attempt at a histo-clinical classification. Acta Pathol. Microbiol. Scand. 64: 31-49.
10. Grabiec, J., and D. A. Owen. 1985. Carcinoma of the stomach in young persons. Cancer 56: 388-396.
11. Chen, X., S. Y. Leung, S. T. Yuen, K. M. Chu, J. Ji, R. Li, A. S. Chan, S. Law, O. G. Troyanskaya, J. Wong, S. So, D. Botstein, and P. O. Brown. 2003. Variation in gene expression patterns in human gastric cancers. Mol. Biol. Cell 14: 3208-3215.
12. Correa, P. 1988. A human model of gastric carcinogenesis. Cancer Res. 48: 3554-3560.
13. Correa, P. 1995. Helicobacter pylori and gastric carcinogenesis. Am. J. Surg. Pathol. 19(Suppl. 1): S37-S43.
14. Correa, P., W. Haenszel, C. Cuello, S. Tannenbaum, and M. Archer. 1975. A model for gastric cancer epidemiology. Lancet 2: 58-60.
15. Baldwin, D. N., B. Shepherd, P. Kraemer, M. K. Hall, L. K. Sycuro, D. M. Pinto-Santini, and N. R. Salama. 2007. Identification of Helicobacter pylori genes that contribute to stomach colonization. Infect. Immun. 75: 1005-1016.
16. Sakagami, T., M. Dixon, J. O'Rourke, R. Howlett, F. Alderuccio, J. Vella, T. Shimoyama, and A. Lee. 1996. Atrophic gastric changes in both Helicobacter felis and Helicobacter pylori infected mice are host dependent and separate from antral gastritis. Gut 39: 639-648. (Pubitemid 26426462)
17. Fox, J. G., B. J. Sheppard, C. A. Dangler, M. T. Whary, M. Ihrig, and T. C. Wang. 2002. Germ-line p53-targeted disruption inhibits Helicobacter-induced premalignant lesions and invasive gastric carcinoma through down-regulation of Th1 proinflammatory responses. Cancer Res. 62: 696-702.
18. Enno, A., J. L. O'Rourke, C. R. Howlett, A. Jack, M. F. Dixon, and A. Lee. 1995. MALToma-like lesions in the murine gastric mucosa after long-term infection with Helicobacter felis: a mouse model of Helicobacter pylori-induced gastric lymphoma. Am. J. Pathol. 147: 217-222.
19. Enno, A., J. O'Rourke, S. Braye, R. Howlett, and A. Lee. 1998. Antigen-dependent progression of mucosa-associated lymphoid tissue (MALT)-type lymphoma in the stomach: effects of antimicrobial therapy on gastric MALT lymphoma in mice. Am. J. Pathol. 152: 1625-1632. (Pubitemid 28275020)
20. Mueller, A., J. O'Rourke, J. Grimm, K. Guillemin, M. F. Dixon, A. Lee, and S. Falkow. 2003. Distinct gene expression profiles characterize the histopathological stages of disease in Helicobacter-induced mucosa-associated lymphoid tissue lymphoma. Proc. Natl. Acad. Sci. USA 100: 1292-1297.
21. Mueller, A., J. O'Rourke, P. Chu, A. Chu, M. F. Dixon, D. M. Bouley, A. Lee, and S. Falkow. 2005. The role of antigenic drive and tumor-infiltrating accessory cells in the pathogenesis of Helicobacter-induced mucosa-associated lymphoid tissue lymphoma. Am. J. Pathol. 167: 797-812. (Pubitemid 41216363)
22. Fox, J. G., A. B. Rogers, M. Ihrig, N. S. Taylor, M. T. Whary, G. Dockray, A. Varro, and T. C. Wang. 2003. Helicobacter pylori-associated gastric cancer in INS-GAS mice is gender specific. Cancer Res. 63: 942-950. (Pubitemid 36278423)
23. Fox, J. G., T. C. Wang, A. B. Rogers, T. Poutahidis, Z. Ge, N. Taylor, C. A. Dangler, D. A. Israel, U. Krishna, K. Gaus, and R. M. Peek, Jr. 2003. Host and microbial constituents influence Helicobacter pylori-induced cancer in a murine model of hypergastrinemia. Gastroenterology 124: 1879-1890.
24. Vilaichone, R. K., V. Mahachai, S. Tumwasorn, J. Y. Wu, D. Y. Graham, and Y. Yamaoka. 2005. Gastric mucosal cytokine levels in relation to host interleukin-1 polymorphisms and Helicobacter pylori cagA genotype. Scand. J. Gastroenterol. 40: 530-539.
25. Rad, R., A. Dossumbekova, B. Neu, R. Lang, S. Bauer, D. Saur, M. Gerhard, and C. Prinz. 2004. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut 53: 1082-1089.
26. Sakai, K., M. Kita, N. Sawai, S. Shiomi, Y. Sumida, K. Kanemasa, S. Mitsufuji, J. Imanishi, and Y. Yamaoka. 2008. Levels of interleukin-18 are markedly increased in Helicobacter pylori-infected gastric mucosa among patients with specific IL18 genotypes. J. Infect. Dis. 197: 1752-1761.
27. Bontems, P., F. Robert, A. Van Gossum, S. Cadranel, and F. Mascart. 2003. Helicobacter pylori modulation of gastric and duodenal mucosal T cell cytokine secretions in children compared with adults. Helicobacter 8: 216-226.
28. El-Omar, E. M., M. Carrington, W. H. Chow, K. E. McColl, J. H. Bream, H. A. Young, J. Herrera, J. Lissowska, C. C. Yuan, N. Rothman, et al. 2000. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404: 398-402.
29. El-Omar, E. M., C. S. Rabkin, M. D. Gammon, T. L. Vaughan, H. A. Risch, J. B. Schoenberg, J. L. Stanford, S. T. Mayne, J. Goedert, W. J. Blot, et al. 2003. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 124: 1193-1201.
30. Lee, A., J. O'Rourke, M. C. De Ungria, B. Robertson, G. Daskalopoulos, and M. F. Dixon. 1997. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 112: 1386-1397.
31. Fujikawa, A., D. Shirasaka, S. Yamamoto, H. Ota, K. Yahiro, M. Fukada, T. Shintani, A. Wada, N. Aoyama, T. Hirayama, et al. 2003. Mice deficient in protein tyrosine phosphatase receptor type Z are resistant to gastric ulcer induction by VacA of Helicobacter pylori. Nat. Genet. 33: 375-381.
32. Tucker, M. S., E. M. Eves, B. H. Wainer, and M. R. Rosner. 1993. Activation of mitogen-activated protein kinase by epidermal growth factor in hippocampal neurons and neuronal cell lines. J. Neurochem. 61: 1376-1387. (Pubitemid 23285096)
33. Stoicov, C., M. Whary, A. B. Rogers, F. S. Lee, K. Klucevsek, H. Li, X. Cai, R. Saffari, Z. Ge, I. A. Khan, et al. 2004. Coinfection modulates inflammatory responses and clinical outcome of Helicobacter felis and Toxoplasma gondii infections. J. Immunol. 173: 3329-3336. (Pubitemid 39142042)
34. Dixon, M. F., R. M. Genta, J. H. Yardley, and P. Correa. 1996. Classification and grading of gastritis: The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am. J. Surg. Pathol. 20: 1161-1181.
35. Chen, X. Y., R. W. van der Hulst, M. J. Bruno, A. van der Ende, S. D. Xiao, G. N. Tytgat, and F. J. Ten Kate. 1999. Interobserver variation in the histopathological scoring of Helicobacter pylori related gastritis. J. Clin. Pathol. 52: 612-615. (Pubitemid 29371907)
36. Mota, R. A., F. Sanchez-Bueno, L. Saenz, D. Hernandez-Espinosa, J. Jimeno, P. L. Tornel, A. Martinez-Torrano, P. Ramirez, P. Parrilla, and J. Yelamos. 2005. Inhibition of poly(ADP-ribose) polymerase attenuates the severity of acute pancreatitis and associated lung injury. Lab. Invest. 85: 1250-1262.
37. Torsten Hothorn, K. H., Mark A. van de Wiel, and Achim Zeileis. 2006. A Lego system for conditional inference. Am. Statistician 60: 257-263.
38. Sawai, N., M. Kita, T. Kodama, T. Tanahashi, Y. Yamaoka, Y. Tagawa, Y. Iwakura, and J. Imanishi. 1999. Role of γ interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Infect. Immun. 67: 279-285. (Pubitemid 29021660)
39. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259: 1739-1742.
40. Zeisberger, S. M., B. Odermatt, C. Marty, A. H. Zehnder-Fjallman, K. Ballmer-Hofer, and R. A. Schwendener. 2006. Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br. J. Cancer 95: 272-281.
41. Sutton, P., S. J. Danon, M. Walker, L. J. Thompson, J. Wilson, T. Kosaka, and A. Lee. 2001. Post-immunisation gastritis and Helicobacter infection in the mouse: a long term study. Gut 49: 467-473.
42. Sporri, R., N. Joller, U. Albers, H. Hilbi, and A. Oxenius. 2006. MyD88-dependent IFN-γ production by NK cells is key for control of Legionella pneumophila infection. J. Immunol. 176: 6162-6171.
43. Mohammadi, M., S. Czinn, R. Redline, and J. Nedrud. 1996. Helicobacter-specific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice. J. Immunol. 156: 4729-4738. (Pubitemid 26174457)
44. Smythies, L. E., K. B. Waites, J. R. Lindsey, P. R. Harris, P. Ghiara, and P. D. Smith. 2000. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-γ, gene-deficient mice. J. Immunol. 165: 1022-1029.
45. Akhiani, A. A., J. Pappo, Z. Kabok, K. Schon, W. Gao, L. E. Franzen, and N. Lycke. 2002. Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells. J. Immunol. 169: 6977-6984. (Pubitemid 36899285)
46. Kamradt, A. E., M. Greiner, P. Ghiara, and S. H. Kaufmann. 2000. Helicobacter pylori infection in wild-type and cytokine-deficient C57BL/6 and BALB/c mouse mutants. Microbes Infect. 2: 593-597.
47. Garhart, C. A., F. P. Heinzel, S. J. Czinn, and J. G. Nedrud. 2003. Vaccine-induced reduction of Helicobacter pylori colonization in mice is interleukin-12 dependent but γ interferon and inducible nitric oxide synthase independent. Infect. Immun. 71: 910-921.
48. Mueller, A., J. O'Rourke, P. Chu, C. C. Kim, P. Sutton, A. Lee, and S. Falkow. 2003. Protective immunity against Helicobacter is characterized by a unique transcriptional signature. Proc. Natl. Acad. Sci. USA 100: 12289-12294.
49. Blanchard, T. G., J. C. Eisenberg, and Y. Matsumoto. 2004. Clearance of Helicobacter pylori infection through immunization: the site of T cell activation contributes to vaccine efficacy. Vaccine 22: 888-897.
50. -/- mice, but only wild-type regulatory T cells suppress Helicobacter pylori gastritis. Infect. Immun. 75: 2699-2707.